Skip to main content
. 2009 Aug 27;9:303. doi: 10.1186/1471-2407-9-303

Figure 4.

Figure 4

Receiver operating characteristics (ROC) analysis based on mean CISH EGFR gene copy number with response to cetuximab therapy as end point. In this model sensitivity was 51.5% (95% CI 33.6–69.2) and specificity was 100% (95% CI 69–100). AUC was 0.77, p = 0.002.